This text is a result of machine translation.
Zelensky called on the international community to provide funds for Ukraine's reconstruction, which is expected to cost $500 billion
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries
XR Service Company GHZ-Tech Nets more than 10 Mn in Angel Round
The strongest demand for XR industrial applications at this stage is in the fields of cultural tourism exhibition and education, while the demand in the industrial field is increasing because certain scenes or processes in the industrial field can also be standardized.
Updated 8 hours ago
hibobi: Unlocking Global Success with Localization Strategy in Diverse Markets
The market in the Middle East has recently gained considerable attention from entrepreneurs worldwide. The hibobi Group, a pioneer in this emerging market, has unique insights in branding and supply chain construction.
Yesterday 10:37 AM
A number of enterprises on the science and innovation board are listed on the "white list" of key enterprises for operation guarantee and transfer
Chip Design Company CMind Completes Pre-A+ Round Financing, 5G Chip Tape out in Q3
Domestic mobile communication chip market is huge, 5G IOT and telematics market is still in the blue ocean, and the market compound annual growth rate is at the forefront of the semiconductor industry.
Yesterday 12:39 AM
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
Fengtai District of Beijing will lift the epidemic prevention zone of the whole region from now on.
WaveFront Ventures: How Can Chinese Companies Win the Global Robotic Race
Mar 24, 2023 02:02 PM
CIRCUE: AI Drives the Revolution of Energy, Leading a Sustainable Future
Mar 23, 2023 12:26 PM